Notices

Title Change in the US Regulatory Status of the TIP Taiwan BIO Futures (“BTF”)
Date 2025/07/11
Per the CFTC notification, the TIP Taiwan Market Biotechnology and Medical Care Index (“TIP Taiwan BIO Index”) is classified as a narrow based security index under U.S. laws. Consequently, the TIP Taiwan BIO Futures contracts (“the Subject Contract”) based on TIP Taiwan BIO Index will fall under the joint jurisdiction of the CFTC and the SEC. Any U.S. investors seeking to trade the Subject Contract shall comply with the requirements stated in the SEC Order (SEC Release No. 34-60194) and the 2010 CFTC Advisory <br >(http://www.cftc.gov/idc/groups/public/@internationalaffairs/documents/ssproject/fsfpadvisory.pdf). As per these requirements, U.S. persons are prohibited from trading the Subject Contract; however, Qualified Institutional Buyers (QIBs) are not subject to this restriction.
print content(Open New Window)